Internal Medicine, Hematology & Oncology · Dallas, TX
NPI
1821217159
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5323 Harry Hines Blvd
Dallas, TX, 75390
Phone (214) 648-4180
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
4,999 services
Medicare patients, 2024
22
Average age 66
Drug cost, 2024
$501K
839 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Sirisha Karri prescribed most often to Medicare patients was Prochlorperazine Maleate, with 119 prescriptions and refills. In total Sirisha Karri wrote 839 Medicare prescriptions that cost $501K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prochlorperazine Maleate Generic | 119 | 119 | 69 | $1,680 |
| Ondansetron Hcl Generic | 74 | 74 | 47 | $608 |
| Gabapentin Generic | 51 | 75 | 14 | $687 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 46 | 46 | 14 | $1,188 |
| Oxycodone Hcl Generic | 44 | 44 | 19 | $486 |
| Entecavir Generic | 39 | 66 | 11 | $1,115 |
| Prednisone Generic | 39 | 52 | 21 | $294 |
| Nivestym Filgrastim-Aafi | 36 | 36 | 16 | $56K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 26 | 26 | 13 | $660 |
| Creon Lipase/Protease/Amylase | 23 | 47 | Under 11 | $30K |
| Morphine Sulfate Er Morphine Sulfate | 23 | 23 | 12 | $801 |
| Dexamethasone Generic | 23 | 30 | 16 | $483 |
| Ondansetron Odt Ondansetron | 21 | 21 | 11 | $211 |
| Granix Tbo-Filgrastim | 15 | 15 | Under 11 | $8,667 |
| Imatinib Mesylate Generic | 15 | 20 | Under 11 | $1,860 |
Brand drugs: 107 claims; generic drugs: 732 claims; opioid claims: 153.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Sirisha Karri were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.